BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®

The application is for an intravenous (IV) route of administration, with the same dosing regimen, presentation and indication as the reference medicine, Ty...

July 26, 2022 | News

Next-generation Diagnostics Paving the Way to Reach Personalized Medicine

New technologies, sequencing methods, novel software algorithms, and multi-omic approaches empower patients to take more active control of their health out...

June 15, 2022 | News

Biocon Biologics to Acquire Viatris' Biosimilar Assets for Up to US$3.335 Billion in Cash and Equity

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASD...

March 03, 2022 | News

Theramex announces an agreement with Enzene Biosciences Limited for the development and commercialisation of Tocilizumab

Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an agreement with Enzene Biosciences Limit...

December 24, 2021 | News

Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar

Prestige BioPharma Ltd. (KRX: 950210) and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred t...

December 10, 2021 | News

China to Position Taizhou as a famous Chinese Medical City

It will build a platform for international exchanges and cooperation in the pharmaceutical and general health industries to further gather innovative...

November 05, 2021 | News

Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment fo...

August 31, 2021 | News

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Osteoporosis is a commonly occurring condition associated with advanced age, and is frequently caused by oestrogen decline in post-menopausal women. It can...

August 29, 2021 | News

Bottmedical enters the market with innovative braces

Bottmedical has developed clear braces made from bio-based polymers, further details of which can be found in an article&...

July 29, 2021 | News

Cytiva and Pall to expand manufacturing capacity and services across geographies

Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. ...

July 27, 2021 | News

Biocon Biologics to Manufacture and Commercialize a Broadly Neutralizing Antibody for India and Select Emerging Markets

Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. , announced today that U.S. based Adagio Therapeutics has gra...

July 26, 2021 | News

Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%

Biocon Ltd , an innovation-led global biopharmaceuticals company, announced its consolidated financial results for the first quarter ended June ...

July 26, 2021 | News

Intas, First Indian company to launch a biosimilar product in the EU

Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreeme...

July 22, 2021 | News

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...

July 20, 2021 | News

Stay Connected